# Clinical Trial Landscape: 05_melanoma_braf_v600e

*Generated: 2026-01-05 18:29:40*

## Summary

- **Total Trials**: 75
- **Flagged for Review**: 0
- **Search Terms Used**: 9

## Phase Distribution

| Phase | Count | Distribution |
|-------|-------|--------------|
| Phase 2 | 17 | ████ 22.7% |
| Phase 1 | 15 | ████ 20.0% |
| Phase 1/Phase 2 | 13 | ███ 17.3% |
| Unknown | 13 | ███ 17.3% |
| Phase 3 | 9 | ██ 12.0% |
| Not Applicable | 6 | █ 8.0% |
| Phase 2/Phase 3 | 1 |  1.3% |
| Early Phase 1 | 1 |  1.3% |

## Status Distribution

- **Recruiting**: 74 (98.7%)
- **Enrolling by invitation**: 1 (1.3%)

## Top Sponsors

| Sponsor | Trial Count |
|---------|-------------|
| National Cancer Institute (NCI) | 6 |
| M.D. Anderson Cancer Center | 4 |
| University of California, San Francisco | 3 |
| University of Nebraska | 2 |
| University of Utah | 2 |
| Dana-Farber Cancer Institute | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| University of Louisville | 1 |
| American Academy of Ophthalmology | 1 |
| Baylor College of Medicine | 1 |
| American Society of Clinical Oncology | 1 |
| University of Colorado, Denver | 1 |
| Bausch Health Americas, Inc. | 1 |
| Megan Daly, MD | 1 |
| Philogen S.p.A. | 1 |

## Interventions

| Intervention | Occurrences |
|--------------|-------------|
| Pembrolizumab | 7 |
| Biospecimen Collection | 7 |
| Magnetic Resonance Imaging | 7 |
| Computed Tomography | 7 |
| Nivolumab | 6 |
| Echocardiography Test | 3 |
| Cyclophosphamide | 2 |
| Aldesleukin | 2 |
| Vemurafenib | 2 |
| Cobimetinib | 2 |
| Questionnaire Administration | 2 |
| Medical Chart Review | 2 |
| Positron Emission Tomography | 2 |
| Ipilimumab | 2 |
| Nivolumab + Relatlimab | 2 |
| Placebo | 2 |
| Plixorafenib | 2 |
| Cetuximab | 2 |
| Multigated Acquisition Scan | 2 |
| Biopsy Procedure | 2 |

## Geographic Distribution

| Country | Trial Count |
|---------|-------------|
| United States | 75 |
| Australia | 14 |
| Canada | 9 |
| Spain | 7 |
| United Kingdom | 7 |
| Italy | 6 |
| France | 5 |
| Israel | 5 |
| Switzerland | 4 |
| Germany | 4 |
| Brazil | 3 |
| Czechia | 3 |
| Poland | 3 |
| Puerto Rico | 2 |
| Hungary | 2 |

## Search Term Provenance

| Term | Source | Confidence |
|------|--------|------------|
| BRAF V600E | manual | 1.0 |
| BRAFV600E | manual | 0.9 |
| BRAF-V600E | manual | 0.9 |
| melanoma | manual | 1.0 |
| BRAF V600E melanoma | manual | 1.0 |
| BRAF V600E metastatic melanoma | llm | 0.9 |
| BRAF V600E cutaneous melanoma | llm | 0.9 |
| cutaneous melanoma | llm | 0.8 |
| BRAF V600E mutated | llm | 0.9 |

## All Trials

| NCT ID | Phase | Status | Sponsor | Title |
|--------|-------|--------|---------|-------|
| [NCT07223424](https://clinicaltrials.gov/study/NCT07223424) | Phase 2 | Recruiting | Diwakar Davar | Patient Preference for Subcutaneous... |
| [NCT07148245](https://clinicaltrials.gov/study/NCT07148245) | N/A | Recruiting | University of Califo... | Characterization of the Symptom Exp... |
| [NCT07237100](https://clinicaltrials.gov/study/NCT07237100) | Phase 2 | Recruiting | Kevin Kim, MD | A Pilot Study of Mirdametinib in Pa... |
| [NCT07015190](https://clinicaltrials.gov/study/NCT07015190) | Phase 3 | Recruiting | IDEAYA Biosciences | A Randomized, Phase 3, Open-label S... |
| [NCT07049276](https://clinicaltrials.gov/study/NCT07049276) | Not Applicable | Recruiting | Melanoma Institute A... | Randomized Controlled Trial of Sele... |
| [NCT06910657](https://clinicaltrials.gov/study/NCT06910657) | Phase 1 | Recruiting | ViroMissile, Inc. | A First-in-human, Phase I, Multi-ce... |
| [NCT07070232](https://clinicaltrials.gov/study/NCT07070232) | Phase 1/Phase 2 | Recruiting | BioNTech SE | A Phase I/II, Open-label, Adaptive ... |
| [NCT06902376](https://clinicaltrials.gov/study/NCT06902376) | Phase 1 | Recruiting | UNC Lineberger Compr... | NEO-COMBAT XL: Neoadjuvant and Main... |
| [NCT07023731](https://clinicaltrials.gov/study/NCT07023731) | Phase 1/Phase 2 | Recruiting | Arvinas Inc. | A Phase 1/2 Clinical Trial to Evalu... |
| [NCT06932757](https://clinicaltrials.gov/study/NCT06932757) | Phase 2 | Recruiting | University of Miami | Phase 2 Trial of Adjuvant Quisinost... |
| [NCT06975293](https://clinicaltrials.gov/study/NCT06975293) | Phase 1/Phase 2 | Recruiting | STORM Therapeutics L... | Open-label, Non-randomized, Multi-c... |
| [NCT06610682](https://clinicaltrials.gov/study/NCT06610682) | Early Phase 1 | Recruiting | Sidney Kimmel Compre... | Feasibility of CSF (Cerebrospinal F... |
| [NCT06712875](https://clinicaltrials.gov/study/NCT06712875) | Phase 1/Phase 2 | Recruiting | Ann & Robert H Lurie... | A Pilot Study Evaluating the Toxici... |
| [NCT06585410](https://clinicaltrials.gov/study/NCT06585410) | Phase 3 | Recruiting | Regeneron Pharmaceut... | A Phase 3 Randomized Study of Intra... |
| [NCT06608511](https://clinicaltrials.gov/study/NCT06608511) | N/A | Recruiting | University of Wiscon... | Liquid Biomarker Study in Melanoma ... |
| [NCT06157099](https://clinicaltrials.gov/study/NCT06157099) | Phase 2 | Recruiting | OHSU Knight Cancer I... | A Decentralized Phase II Randomized... |
| [NCT06466434](https://clinicaltrials.gov/study/NCT06466434) | Not Applicable | Recruiting | M.D. Anderson Cancer... | Prebiotic Food-enriched Diet (PreFE... |
| [NCT06475989](https://clinicaltrials.gov/study/NCT06475989) | Phase 3 | Recruiting | ECOG-ACRIN Cancer Re... | A Randomized Phase III Study of BRA... |
| [NCT05896839](https://clinicaltrials.gov/study/NCT05896839) | Phase 1/Phase 2 | Recruiting | National Cancer Inst... | A Phase 2 Study of Nivolumab and Ip... |
| [NCT06475807](https://clinicaltrials.gov/study/NCT06475807) | Not Applicable | Recruiting | University of Pittsb... | Cancer Nutrition Study: CaNS - A Pi... |
| [NCT06440850](https://clinicaltrials.gov/study/NCT06440850) | Phase 2 | Recruiting | City of Hope Medical... | A Pilot Clinical Trial of Vemurafen... |
| [NCT06582745](https://clinicaltrials.gov/study/NCT06582745) | Phase 2 | Recruiting | Cook Children's Heal... | Targeted Approach to Langerhans Cel... |
| [NCT06102902](https://clinicaltrials.gov/study/NCT06102902) | Phase 1 | Recruiting | National Cancer Inst... | A Phase 1 Study of ZEN003694 (ZEN-3... |
| [NCT06112314](https://clinicaltrials.gov/study/NCT06112314) | Phase 3 | Recruiting | Immunocore Ltd | A Phase 3 Randomized, Controlled St... |
| [NCT05828069](https://clinicaltrials.gov/study/NCT05828069) | Phase 2 | Recruiting | National Cancer Inst... | Phase 2 Study of Tovorafenib (DAY10... |
| [NCT06194929](https://clinicaltrials.gov/study/NCT06194929) | Phase 1/Phase 2 | Recruiting | University of Utah | Phase 1b/2 Trial of Defactinib and ... |
| [NCT06150664](https://clinicaltrials.gov/study/NCT06150664) | Phase 1 | Recruiting | Compass Therapeutics | A Phase 1, Open-Label, Multiple-Asc... |
| [NCT05868629](https://clinicaltrials.gov/study/NCT05868629) | N/A | Recruiting | Novartis Pharmaceuti... | Clinical Study To Further Evaluate ... |
| [NCT06035744](https://clinicaltrials.gov/study/NCT06035744) | Phase 1 | Recruiting | Cullinan Therapeutic... | A Phase 1 First-in-Human Study to I... |
| [NCT06074588](https://clinicaltrials.gov/study/NCT06074588) | Phase 3 | Recruiting | Merck Sharp & Dohme ... | A Randomized, Open-label, Phase 3 S... |
| [NCT05970497](https://clinicaltrials.gov/study/NCT05970497) | Phase 1/Phase 2 | Recruiting | Krystal Biotech, Inc... | A Phase 1/2, Open-Label, Multi-Cent... |
| [NCT05839912](https://clinicaltrials.gov/study/NCT05839912) | Not Applicable | Recruiting | Craig L Slingluff, J... | Lymph Node Excision (LNEx) for Pati... |
| [NCT06270706](https://clinicaltrials.gov/study/NCT06270706) | Phase 1 | Recruiting | Pliant Therapeutics,... | A Phase 1a/1b Multicenter, Open-lab... |
| [NCT05313243](https://clinicaltrials.gov/study/NCT05313243) | Phase 2 | Recruiting | Yale University | Phase 2 Study of Pembrolizumab and ... |
| [NCT05694715](https://clinicaltrials.gov/study/NCT05694715) | Phase 1 | Recruiting | University of Califo... | Combination Therapy of Niraparib an... |
| [NCT05684965](https://clinicaltrials.gov/study/NCT05684965) | Phase 1/Phase 2 | Recruiting | Xilio Development, I... | A First-in-Human, Multicenter, Phas... |
| [NCT05786924](https://clinicaltrials.gov/study/NCT05786924) | Phase 1/Phase 2 | Recruiting | Institut de Recherch... | A Phase 1/2, Open-label Study of Or... |
| [NCT05704647](https://clinicaltrials.gov/study/NCT05704647) | Phase 2 | Recruiting | M.D. Anderson Cancer... | Phase II Study of Nivolumab in Comb... |
| [NCT05503797](https://clinicaltrials.gov/study/NCT05503797) | Phase 2 | Recruiting | Fore Biotherapeutics | A Phase 2 Master Protocol to Assess... |
| [NCT05538130](https://clinicaltrials.gov/study/NCT05538130) | Phase 1 | Recruiting | Pfizer | A PHASE 1A/B OPEN-LABEL MASTER STUD... |
| [NCT05607095](https://clinicaltrials.gov/study/NCT05607095) | Phase 1 | Recruiting | Memorial Sloan Kette... | A Pilot Trial of Autologous Tumor I... |
| [NCT05576896](https://clinicaltrials.gov/study/NCT05576896) | Phase 2 | Recruiting | Northwestern Univers... | A Single-Arm, Phase II Study of Aut... |
| [NCT05562791](https://clinicaltrials.gov/study/NCT05562791) | Phase 1 | Recruiting | Memorial Sloan Kette... | Pilot Study of 68Gallium PSMA-PET/C... |
| [NCT04971499](https://clinicaltrials.gov/study/NCT04971499) | Phase 1/Phase 2 | Recruiting | April Salama, M.D. | A Study of Dapansutrile Plus Pembro... |
| [NCT05225428](https://clinicaltrials.gov/study/NCT05225428) | Not Applicable | Recruiting | Dana-Farber Cancer I... | Video Education With Result Depende... |
| [NCT04712877](https://clinicaltrials.gov/study/NCT04712877) | N/A | Recruiting | Lung Cancer Mutation... | LEADER Neoadjuvant Screening Trial:... |
| [NCT05267626](https://clinicaltrials.gov/study/NCT05267626) | Phase 1/Phase 2 | Recruiting | Aulos Bioscience, In... | A Phase 1/2, First-in-Human, Open L... |
| [NCT04844528](https://clinicaltrials.gov/study/NCT04844528) | Phase 2 | Recruiting | University of Utah | Randomized Phase 2 Studying the Eff... |
| [NCT04697576](https://clinicaltrials.gov/study/NCT04697576) | Phase 1 | Recruiting | Carlo Contreras | Intralesional Influenza Vaccine for... |
| [NCT05009992](https://clinicaltrials.gov/study/NCT05009992) | Phase 2 | Recruiting | University of Califo... | A Combination Therapy Trial Using a... |

*... and 25 more trials (see trials.csv for full list)*
